SUPERNUS PHARMACEUTICALS, INC. Interest Expense
SUPERNUS PHARMACEUTICALS, INC. (SUPN) reported Interest Expense of $0 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-08
- SUPERNUS PHARMACEUTICALS, INC. interest expense for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-09-30 was $0.00, a 100.00% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-06-30 was $910.00K, a 49.72% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. interest expense for the quarter ending 2023-03-31 was $1.50M, a 22.50% decline year-over-year.
- SUPERNUS PHARMACEUTICALS, INC. interest expense for fiscal 2021 was $19.70M, a 1.34% increase from fiscal 2020.
- SUPERNUS PHARMACEUTICALS, INC. interest expense for fiscal 2020 was $19.43M, a 6.74% increase from fiscal 2019.
- SUPERNUS PHARMACEUTICALS, INC. interest expense for fiscal 2019 was $18.21M, a 31.55% increase from fiscal 2018.
- SUPERNUS PHARMACEUTICALS, INC. interest expense for fiscal 2018 was $13.84M, a 10228.36% increase from fiscal 2017.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-08 | |||
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | $910.00K derived: sum of 2 quarters · filed 2023-11-08 | $2.42M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $910.00K 10-Q · filed 2023-08-08 | $2.42M 10-Q · filed 2023-08-08 | ||
| 2023-03-31 | $1.50M 10-Q · filed 2024-05-08 | |||
| 2022-09-30 | $1.72M 10-Q · filed 2023-11-08 | $3.53M derived: sum of 2 quarters · filed 2023-11-08 | $5.48M 10-Q · filed 2023-11-08 | $7.68M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | $1.81M 10-Q · filed 2023-08-08 | $3.75M 10-Q · filed 2023-08-08 | $5.96M derived: sum of 3 quarters · filed 2023-08-08 | $11.88M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.94M 10-Q · filed 2023-05-09 | $4.15M derived: sum of 2 quarters · filed 2023-05-09 | $10.07M derived: sum of 3 quarters · filed 2023-05-09 | $15.54M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13 | $8.13M derived: sum of 2 quarters · filed 2022-11-09 | $13.60M derived: sum of 3 quarters · filed 2022-11-09 | $19.70M 10-K · filed 2022-04-13 |
| 2021-09-30 | $5.92M 10-Q · filed 2022-11-09 | $11.39M derived: sum of 2 quarters · filed 2022-11-09 | $17.49M 10-Q · filed 2022-11-09 | $19.27M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $5.47M 10-Q · filed 2022-08-08 | $11.56M 10-Q · filed 2022-08-08 | $13.34M derived: sum of 3 quarters · filed 2022-08-08 | $19.43M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $6.10M 10-Q · filed 2022-05-12 | $7.87M derived: sum of 2 quarters · filed 2022-05-12 | $13.96M derived: sum of 3 quarters · filed 2022-05-12 | $19.78M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13 | $7.87M derived: sum of 2 quarters · filed 2022-04-13 | $13.68M derived: sum of 3 quarters · filed 2022-04-13 | $19.43M 10-K · filed 2022-04-13 |
| 2020-09-30 | $6.09M 10-Q · filed 2021-11-05 | $11.90M derived: sum of 2 quarters · filed 2021-11-05 | $17.66M 10-Q · filed 2021-11-05 | $18.93M derived: sum of 4 quarters · filed 2022-04-13 |
| 2020-06-30 | $5.82M 10-Q · filed 2021-08-06 | $11.57M 10-Q · filed 2021-08-06 | $12.85M derived: sum of 3 quarters · filed 2022-04-13 | $18.51M derived: sum of 4 quarters · filed 2022-04-13 |
| 2020-03-31 | $5.75M 10-Q · filed 2021-05-07 | $7.03M derived: sum of 2 quarters · filed 2022-04-13 | $12.69M derived: sum of 3 quarters · filed 2022-04-13 | $18.08M derived: sum of 4 quarters · filed 2022-04-13 |
| 2019-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-13 | $6.94M derived: sum of 2 quarters · filed 2022-04-13 | $12.33M derived: sum of 3 quarters · filed 2022-04-13 | $18.21M 10-K · filed 2022-04-13 |
| 2019-09-30 | $5.66M 10-Q · filed 2020-11-06 | $11.05M derived: sum of 2 quarters · filed 2020-11-06 | $16.93M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $5.39M 10-Q · filed 2020-08-17 | $11.27M 10-Q · filed 2020-08-17 | ||
| 2018-12-31 | $4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-08 | $8.80M derived: sum of 2 quarters · filed 2021-03-08 | $13.12M derived: sum of 3 quarters · filed 2021-03-08 | $13.84M 10-K · filed 2021-03-08 |
| 2018-09-30 | $4.37M 10-Q · filed 2018-11-09 | $8.70M derived: sum of 2 quarters · filed 2018-11-09 | $9.41M 10-Q · filed 2018-11-09 | $9.40M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $4.32M 10-Q · filed 2018-08-09 | $5.04M 10-Q · filed 2018-08-09 | $5.03M derived: sum of 3 quarters · filed 2020-02-28 | $5.03M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $717.00K 10-Q · filed 2018-05-10 | $703.00K derived: sum of 2 quarters · filed 2020-02-28 | $704.00K derived: sum of 3 quarters · filed 2020-02-28 | $762.00K derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | -$13.00K derived: sum of 2 quarters · filed 2020-02-28 | $45.00K derived: sum of 3 quarters · filed 2020-02-28 | $134.00K 10-K · filed 2020-02-28 |
| 2017-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $59.00K derived: sum of 2 quarters · filed 2018-11-09 | $148.00K 10-Q · filed 2018-11-09 | $115.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $58.00K 10-Q · filed 2018-08-09 | $147.00K 10-Q · filed 2018-08-09 | $114.00K derived: sum of 3 quarters · filed 2019-03-01 | $316.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $90.00K 10-Q · filed 2018-05-10 | $56.00K derived: sum of 2 quarters · filed 2019-03-01 | $258.00K derived: sum of 3 quarters · filed 2019-03-01 | $454.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $168.00K derived: sum of 2 quarters · filed 2019-03-01 | $364.00K derived: sum of 3 quarters · filed 2019-03-01 | $543.00K 10-K · filed 2019-03-01 |
| 2016-09-30 | $202.00K 10-Q · filed 2017-11-09 | $398.00K derived: sum of 2 quarters · filed 2017-11-09 | $577.00K 10-Q · filed 2017-11-09 | $802.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $196.00K 10-Q · filed 2017-08-03 | $375.00K 10-Q · filed 2017-08-03 | $600.00K derived: sum of 3 quarters · filed 2018-03-01 | $892.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $179.00K 10-Q · filed 2017-05-09 | $404.00K derived: sum of 2 quarters · filed 2018-03-01 | $696.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.03M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $225.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $517.00K derived: sum of 2 quarters · filed 2018-03-01 | $848.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.23M 10-K · filed 2018-03-01 |
| 2015-09-30 | $292.00K 10-Q/A · filed 2017-01-20 | $623.00K derived: sum of 2 quarters · filed 2017-01-23 | $1.00M 10-Q/A · filed 2017-01-20 | $2.19M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $331.00K 10-Q/A · filed 2017-01-23 | $712.00K 10-Q/A · filed 2017-01-23 | $1.90M derived: sum of 3 quarters · filed 2017-03-16 | $3.19M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | $381.00K 10-Q/A · filed 2017-01-20 | $1.57M derived: sum of 2 quarters · filed 2017-03-16 | $2.86M derived: sum of 3 quarters · filed 2017-03-16 | $4.14M derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | $1.19M derived: 10-K 12 month − 10-Q/A 9 month · filed 2017-03-16 | $2.48M derived: sum of 2 quarters · filed 2017-03-16 | $3.76M derived: sum of 3 quarters · filed 2017-03-16 | $4.96M 10-K · filed 2017-03-16 |
| 2014-09-30 | $1.29M 10-Q/A · filed 2017-01-20 | $2.57M derived: sum of 2 quarters · filed 2017-01-20 | $3.77M 10-Q/A · filed 2017-01-20 | $5.88M derived: sum of 4 quarters · filed 2017-01-20 |
| 2014-06-30 | $1.28M 10-Q · filed 2015-08-07 | $2.48M 10-Q · filed 2015-08-07 | $4.59M derived: sum of 3 quarters · filed 2017-01-20 | $7.46M derived: sum of 4 quarters · filed 2017-01-20 |
| 2014-03-31 | $1.21M 10-Q · filed 2015-05-06 | $3.31M derived: sum of 2 quarters · filed 2017-01-20 | $6.18M derived: sum of 3 quarters · filed 2017-01-20 | $8.33M derived: sum of 4 quarters · filed 2017-01-20 |
| 2013-12-31 | $2.11M derived: 10-K/A 12 month − 10-Q 9 month · filed 2017-01-20 | $4.98M derived: sum of 2 quarters · filed 2017-01-20 | $7.12M derived: sum of 3 quarters · filed 2017-01-20 | $7.85M 10-K/A · filed 2017-01-20 |
| 2013-09-30 | $2.87M 10-Q · filed 2014-11-12 | $5.01M derived: sum of 2 quarters · filed 2014-11-12 | $5.74M 10-Q · filed 2014-11-12 | $6.54M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $2.14M 10-Q · filed 2014-08-12 | $2.87M 10-Q · filed 2014-08-12 | $3.67M derived: sum of 3 quarters · filed 2015-03-12 | $4.55M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $727.00K 10-Q · filed 2014-05-13 | $1.53M derived: sum of 2 quarters · filed 2015-03-12 | $2.41M derived: sum of 3 quarters · filed 2015-03-12 | $3.34M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $804.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $1.68M derived: sum of 2 quarters · filed 2015-03-12 | $2.61M derived: sum of 3 quarters · filed 2015-03-12 | $3.58M 10-K · filed 2015-03-12 |
| 2012-09-30 | $880.00K 10-Q · filed 2013-11-13 | $1.81M derived: sum of 2 quarters · filed 2013-11-13 | $2.77M 10-Q · filed 2013-11-13 | $3.28M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-06-30 | $929.00K 10-Q · filed 2013-08-14 | $1.89M 10-Q · filed 2013-08-14 | $2.40M derived: sum of 3 quarters · filed 2014-03-21 | $2.90M derived: sum of 4 quarters · filed 2014-03-21 |
| 2012-03-31 | $962.00K 10-Q · filed 2013-05-15 | $1.47M derived: sum of 2 quarters · filed 2014-03-21 | $1.97M derived: sum of 3 quarters · filed 2014-03-21 | $2.47M derived: sum of 4 quarters · filed 2014-03-21 |
| 2011-12-31 | $509.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | $1.01M derived: sum of 2 quarters · filed 2014-03-21 | $1.51M derived: sum of 3 quarters · filed 2014-03-21 | $1.87M 10-K · filed 2014-03-21 |
| 2011-09-30 | $499.00K 10-Q · filed 2012-11-02 | $998.00K derived: sum of 2 quarters · filed 2012-11-02 | $1.36M 10-Q · filed 2012-11-02 | |
| 2011-06-30 | $499.00K 10-Q · filed 2012-08-13 | $859.00K 10-Q · filed 2012-08-13 | ||
| 2011-03-31 | $360.00K 10-Q · filed 2012-06-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |